Results 111 to 120 of about 768,171 (308)
Circulation. 2018;138:1608–1609. DOI: 10.1161/CIRCULATIONAHA.118.033684 1608 Mateusz Śpiewak, MD, PhD To the Editor: The study by Penicka et al1 recently published in Circulation is interesting because accurate quantification of mitral regurgitation is ...
M. Śpiewak
semanticscholar +1 more source
Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner+10 more
wiley +1 more source
Late Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Background— The pathological spectrum of degenerative diseases of the mitral valve (MV) that causes mitral regurgitation (MR) is broad, and there is limited information on late outcomes of MV repair in various subgroups of patients and pathologies.
T. David+3 more
semanticscholar +1 more source
Abstract Aims Plasma volume status (PVS) is recognized as a marker of systemic congestion, but its clinical utility in patients with mitral regurgitation (MR) undergoing transcatheter edge‐to‐edge mitral valve repair (M‐TEER) has not been well established. This study aimed to evaluate the prognostic significance of PVS in these patients.
Ai Kagase+30 more
wiley +1 more source
Background—Aortic valve stenosis (with or without aortic regurgitation and without associated mitral stenosis) in adults in the Western world has been considered in recent years to most commonly be the result of degenerative or atherosclerotic disease ...
W. Roberts, J. Ko
semanticscholar +1 more source
Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang+18 more
wiley +1 more source
Anesthetic management in pregnant women with Fontan circulation: a case series
Background Given the advances in medicine, women with Fontan circulation are now reaching childbearing age. However, data on the mode of delivery and anesthetic management of these patients are limited.
Ai Fujita+3 more
doaj +1 more source
Disturbance of intracardiac hemodynamics in children with chronic rheumatic cardiac disease [PDF]
By means of Doppler echocardiography there have been studied disturbances of intracardiac hemodynamics in 44 children aged 8-17 years with chronic rheumatic cardiac disease and developed mitral aortal and combined heart defects, as well as in chronic ...
Kondratiev V.A.+2 more
doaj
The mathematical modeling of the cardiovascular system is a simple and noninvasive method to comprehend hemodynamics and the operating mechanism of the mechanical circulatory assist device.
Hongtao Liu+3 more
doaj +1 more source
Background— The optimal treatment for ischemic mitral regurgitation remains actively debated. Our objective was to evaluate the relationship between ischemic mitral regurgitation treatment strategy and survival.
A. Castleberry+11 more
semanticscholar +1 more source